BROMODOMAIN INHIBITORS TO PREVENT DEVELOPMENT OF RESISTANCE TO TARGETED KINASE INHIBITORS IN SCHWANNOMAS

The University Of Central Florida Board Of Trustees, Orlando FL

Investigators